This study has examined whether estrogen regulates GABA transporter synthesis and activity in the female rat brain. In the first experiment in situ hybridization studies examined the effects of ovariectomy on cellular GABA transporter-l (GAT-1) mRNA content. A 25% decrease in GAT-1 mRNA expression was detected within the medial preoptic area (MPOA) but not the parietal cortex, magnocellular preoptic nucleus (Mg-POA) or caudate-putamen (C-P). Estrogen replacement for 7 d returned GAT-1 mRNA content of MPOA cells to levels observed in intact rats. In the second experiment, the effect of increased brain GABA concentrations on GAT-1 mRNA expression was investigated by treating rats with y-vinyl GABA, a GABA-transaminase inhibitor.
Although resulting in a twofold increase in tissue GABA content, in situ hybridization experiments revealed no changes in GAT-1 transcript expression. A third series of experiments examined GABA transporter activity in vitro using a 3H GABA uptake assay in MPOA, cortex, and C-P punches. Nipecotic acid (10 PM) reduced specific 3H GABA uptake in all three brain regions while 100 PM p-alanine only reduced uptake in the MPOA. Estrogen treatment for 7 d resulted in a significant increase in 3H GABA uptake in the MPOA but not the cortex or C-P. The presence of a putative estrogen response element in the GAT-1 gene and the effects demonstrated here on GAT-1 mRNA content and GABA transporter activity indicate that estrogen may influence GAT-1, gene transcription to alter GABA transporter function within the MPOA but not the C-P or cortex.
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The preoptic area is associated with both hypothalamic and limbit systems and implicated in the control of diverse autonomic and neuroendocrine functions as well as a variety of reproductive behaviours (Boulant and Dean, 1986; Freeman, 1994; McGinty et al., 1994; Numan, 1994 ). An important feature of the preoptic area is that it contains one of the largest populations of cells expressing gonadal steroid receptors in the CNS (Pfaff and Keiner, 1973; Sar, 1988; Simerly et al., 1990; Herbison and Theodosis, 1992) and, as such, serves as a brain site at which these hormones can modulate neural functioning.
In the female rat, in particular, circulating estrogens have been shown to influence both the electrical and synthetic activity of preoptic neurones (Yagi, 1973; Jones et al., 1988) and, although ill-defined, estrogen actions in this brain region are known to be critical for the regulation of reproduction by the nervous system (Petersen and Barraclough, 1989; Numan, 1994; Pfaff et al., 1994) . The most numerous cell type expressing nuclear estrogen receptors in the preoptic area is that synthesizing gamma aminobutyric acid (GABA); approximately 30% of preoptic estrogen receptor-containing cells contain glutamic acid decarboxylase (GAD), the synthetic enzyme for GABA (Flugge et al., 1986; Herbison et al., 1993) . Studies measuring GABA turnover and extracellular GABA concentrations in the preoptic area have indicated that the estrogen receptors in these GABA neurones are likely to be of functional significance as ovariectomy decreases (Ondo et al., 1982) , and estrogen replacement increases Demling et al., 1985; Herbison et al., 1989 , basal and potassium-evoked GABA levels in this area. However, the mechanisms by which estrogen acts on preoptic GABA neurones to influence extracellular GABA concentrations are not known. Gonadal steroids have been reported to regulate GAD synthesis and activity in a variety of brain regions (Wallis and Luttge, 1980; Weiland, 1992; McCarthy et al., 1995) , but appear unlikely to regulate GAD in the female preoptic area as GAD,, mRNA expression and GAD activity (Wallis and Luttge, 1980; O'Conner et al., 1988; Fleischmann et al., 1992) in this region are not influenced directly by ovariectomy or estrogen treatment. Hence, it would appear that the preoptic area provides an example of a brain region where changes in extracellular GABA concentrations may not always be related to GAD activity.
Such observations raise the question of whether gonadal steroids may modulate the other principal determinant of extracellular GABA concentrations, the GABA transporter. Recent molecular cloning studies have identified the presence of three GAB A transporters in the rat brain, termed GAT-1, CAT-2, and GAT-3, which exhibit differences in their distribution, pharmacology and ability to transport GABA (Guastella et al., 1990; Borden et al., 1992; Clark et al., 1992) . However, it is not known whether gonadal steroids may influence GABA transport in the nervous system. In this study we have examined whether estrogen, the principal gonadal steroid of the female, may play a physiological role in regulating GABA transport in the female rat brain by examining the effect of gonadal steroid manipulation The Journal of Neuroscience, December 1995, 15(12) 8303 on both GAT-1 mRNA expression and in vitro GABA transporter activity.
Materials and Methods
Adult female Wistar rats from the Babraham colony were maintained in a light and temperature controlled environment (lights on 05:00-19: 00 hr, 22°C) with food and water freely available. Metestrous rats were determined by daily vaginal smear and used on the morning of metestrus following two 4 d estrous cycles. All ovariectomies were undertaken on animals anesthetized with Avertin (2% tribromoethanol, 1.0 ml/ 100 gm body weight, i.p.) 3-4 weeks prior to experimentation and all procedures were conducted in accordance with Home Office requirements for Animal Scientific Procedures (Project 80/00704).
Experiment 1: effect of ovariectomy and estrclgen-replacement on GAT-I mRNA expression.
In the first part of this experiment, five ovariectomized rats and five metestrous rats were used. In the second part, undertaken at a later date, three groups of rats were ovariectomized and 3 weeks later given subcutaneous silastic capsule implants (length 14 mm, id. 0.062 in., o.d. 0.125 in.; Dow Corning USA). In the first group of rats (OVX; n = 5) implants contained the vehicle ethyl oleate alone while animals in the second group (OVX-E7d; n = 5) received silastic implants filled with a 50 pg 17-B estradiol/ml ethyl oleate solution. Animals were killed 7 d later. A third group (OVX-E24h; n = 5) received the same estradiol-filled capsule but 24 hr prior to decapitation. Estradiol capsules prepared and administered in this way return plasma estradiol concentrations to physiological levels observed at metestrus within 24h (Leipheimer et al., 1984) . All rats were stunned by a blow to the back of the neck and decapitated between IO:00 and 1l:OO A.M., their brains removed and frozen on dry ice. Fresh frozen sections (15 pm thick) were cut in the coronal plane, thaw mounted onto gelatinized slides and stored at ~70°C.
An antisense oligonucleotide complementary to nucleotides 153-l 85 of the rat GAT-I GABA transporter gene (Guastella et al., 1990) was synthesized using an automated DNA synthesizer and purified by gel filtration. The probe (100 ng) was 3' end-labeled to a specific activity of approximately lo" cpm/p,g by incubation with ?SS-dATP (1000-l 500 Ci/mmol; New England Nuclear NEG 034H) and 50 U terminal deoxynucleotidyl transferase (Pharmacia, UK) in tailing buffer at 37°C for 30 min. The radiolabelled probe was purified on a Sephadex G-50 column Brain sections from each experiment were processed simultaneously. Frozen sections were warmed to room temperature with a hair dryer and hxed in 4% paraformaldehyde/O. 1 M phosphate buffer for 20 min. Sections were then rinsed in 0.1 M phosphate buffer saline before being dehydrated through a series of graded ethanols and left to air drv at room temperature. For hybridization, the ?S labeled probe was dcluted in hvbridization buffer (50% deionized formamide. 4 X SSC. 10% dextran sulfate, 1 X Denhardt's solution, 250 pg/ml sheared salmon testis DNA, 0.3% B-mercaptoethanol) to a final concentration of approximately 2 X IO' cpm/pl, and 250 p,l of diluted probe was applied to each slide containing four coronal brain sections. Following an overnight hybridization at 37°C sections were rinsed in 1 X SSC at room temperature (5 min), three times at 55°C (30 min each) and then for 1 hr at room temperature. After a brief rinse in dH,O followed by 70% ethanol/300 mM ammonium acetate (30 set) and then absolute alcohol (30 set), sections were left to air dry before being apposed to Hyperfilm B-Max (Amersham) for 3 weeks, Slides were then dipped in Ilford K-5 nuclear track emulsion and exposed for 8-l 0 weeks in light-tight boxes. After developing with Ilford Phenisol (1:5, 5 min at 20°C) slides were counterstained lightly with methylene blue and coverslipped. We have reported previously that this oligonucleotide recognizes a single 4.5 kb band on Northern analysis (Augood et al., 1995) and further assessed specificity of the oligonucleotide in these experiments by use of competition experiments in which the radiolabeled probe was hybridised to sections in the presence of a 25.fold excess of unlabeled probe. Two groups of ovariectomized rats were used. The first group (n = 5) received a daily subcutaneous injection of the GABA transaminase inhibitor, gamma vinvl GABA (GVG: Viuabatrin: Marion Merrell Dow. U.K.; 150 mg/kg), dissolved in 2-300 il of 0.9% saline for 7 d while the second group (n = 5) received the 0.9% saline injection alone. Animals were then decapitated between 10:00 and I I :00 hr the following day and their brains cut into two halves in the sagittal plane. The right half was frozen on dry ice and processed for GAT-1 in situ hybridization as detailed above. The left half of the brain was cut so that a coronal block approximately 1.0-I .5 mm thick containing the anterior commisure (equivalent to plates 1 Y-22 of Swanson, 1992 ) was obtained and a tissue punch of the preoptic area (diameter 1 .O mm) and parietal cortex (diameter 1.5 mm) taken. Tissue punches were frozen immediately in Eppendorf tubes and processed for tissue GABA and protein content. Protein analysis was carried out using the Folin-Lowry method and the GABA content determined using reverse phase high-performance liquid chromatography with fluorescence detection as described previously .
Experiment 3: effect of estrogen-treutmetzt on -'H-GABA uptake in vitro. Female rats were ovariectomized and 3 weeks later were given subcutaneous silastic capsules containing either sesame oil alone (OVX; n = 6) or sesame oil containing 50 p,g/ml I7 B-estradiol (OVX-E7d; n = 6) under Avertin anaesthesia. One week later, between Y:30 and 11: 00 hr, rats were decapitated, their brains quickly removed and a complete 3-4 mm thick coronal brain section containing the preoptic area and hypothalamus glued to a cutting block with cyanoacrylate glue. Brains were then placed in a vibroslice (752M Campden Instruments, UK) cutting chamber containing ice cold, artificial cerebrospinal fluid (aCSF; composition in mM, NaCl 124, KC1 5, KH,P04 1.25, NaHCO, 25, MgSO, 2, CaCl, 2, glucose 5) bubbled with 95% O,, 5% CO,. Coronal sections, 300 pm thick, were then cut through the preoptic area and the two sections on either side of the cut bisecting the anterior commissure (plates 19-21, Swanson, 1992) were collected into ice cold aCSF and unilateral punches taken of the medial preoptic area (diameter 1.0 mm), caudate-putamen (diameter 1.5 mm), and parietal cortex (diameter I .8 mm). The 12 punches obtained from each animal were then placed together in groups of three (one preoptic, one caudate-putamen, one cortex) in four incubation chambers each containing 300 pl of gassed aCSF maintained at 37°C. After 40 min the aCSF was replaced with 300 pl of aCSF containing 50 nM 'H GABA (86 Cilmmol; Amersham, UK) and 100 FM aminoxyacetic acid (Sigma, UK), the GABAtransaminase inhibitor (Clark et al., lYY2) , for IO (chambers l-3) or 20 (chamber 4) min. For each animal, punches in the first chamber had 1 mM unlabeled GABA included in the ?H GABA-aCSF and served as a control for nonspecific ?H GABA accumulation. Sections in the second chamber were incubated in the 'H GABA-aCSF for 10 min while 100 PM B-alanine (Sigma, UK) was included in the ?H GABA-aCSF of the third chamber. In an earlier set of experiments using intact female rats (n = 9), the effects of 10 PM 5 nipecotic acid (Sigma, UK) on ?H GABA uptake in preoptic, caudate-putamen, and parietal cortex punches was examined in a similar manner by including nipecotic acid in the 10 min 'H GABA-aCSF incubation of one chamber but not another. At the end of the ?H GABA incubation period, the tritiated GABA was removed and replaced with ice-cold aCSE Individual punches were then removed from the wells and placed in Eppendorfs containing aCSF on ice. This aCSF was changed three times with 300 (*I of fresh ice-cold aCSF before being replaced with 300 pl of distilled water. At least 30 min later, each Eppendorf was sonicated for 30 set and centrifuged. The supernatant was removed and placed in a scintillation vial with 4 ml of Ultima Gold scintillation fluid and counted on a Packard Tricarb 1YOOCA counter. Protein analysis of the centrifuged pellet was carried out using the Folin-Lowry procedure.
Datu unulysis. For in situ hybridization experiments, numbers of silver grains overlying individual cells in the medial and lateral divisions of the medial preoptic nucleus (MPN, plates 20 and 21 of Swanson, lY92), anteroventral periventricular preoptic nucleus (AVPv, plate 19), magnocellular preoptic nucleus (MgPOA; plates 20 and 21), caudateputamen (plate 19) and parietal cortex (all layers, plates 20 and 21) were determined using a Leica Orthoplan microscope coupled to a Joyce-Loebl Magiscan analyzer. In each of these regions, 18-25 labeled cells were analysed from both sides of the brain of each animal. Cells within the central nucleus of the MPN were excluded from the analysis as the density of cells in this area precluded us from determining precisely which overlying silver grains were related to which cells. Initially, the number of silver grains overlying cells in the excess unlabelled probe control sections were determined and, in experimental sections, only those cells expressing numbers of silver grains greater than three times that of controls were used for analysis. For each rat and each region an average silver grain count/cell was determined and these values combined to give experimental group means. Earlier experiments in which we coexpressed radioactive standards with hybridized brain sections showed that our detection system exhibited a linear relationship between optical density and radioactivity levels present in the brain sections and that this was not saturated at even the highest level of signal. In the estrogen replacement experiment involving three experi- Figure 1 . A direct autoradiograph print showing the distribution of GAT-1 mRNA in the coronal plane of an intact metestrous female rat visualized using the YS-GAT-1 oligonucleotide and in situ hybridization. A strong signal is noted in the magnocellular preoptic nucleus (Mg-POA), medial and lateral septum and suprachiasmatic nucleus (SClv). Scattered, highly expressing cells are evident throughout the cerebral cortex and striatum as discrete black dots. Overall GAT-1 mRNA expression is less intense within the medial preoptic nucleus (MPN) although relatively high expression is observed in the central division of the MPN (black dot within MPN).
mental groups, statistical analysis was carried using a nonparametric ANOVA followed by the post-hoc Dunn's multiple comparison test. Statistical analysis in other experiments was undertaken with the nonparametric Mann-Whitney U test.
In the 3H GABA uptake studies, the amount of 3H GABA in each tissue punch, recorded as disintegrations per minute (dpm), was divided by its total protein content to give dpm/pg protein. For each animal the dpm/p,g protein values from punches in the first chamber incubated with excess unlabeled GABA, and reflecting nonspecific 3H GABA incorporation, were subtracted from punch values in the other three parallel chambers to give specific 3H GABA uptake (Boden et al., 1992) . Nonparametric statistical analyses were undertaken using ANOVA followed by Dunn's test for comparison between the three different brain regions and paired-or Mann-Whitney U tests for transport inhibitor and OVX versus OVX-E7d comparisons, respectively.
Results
In situ hybridization for GAT-1 mRNA
The regional distribution of GAT-1 mRNA was observed in coronal brain sections following film (Fig. 1) and emulsion (Fig. 2) autoradiography. Cells expressing GAT-1 transcripts were distributed throughout the coronal brain sections in a heterogeneous manner. The most abundant signal was detected in the magnocellular preoptic area (Mg-POA; Figs. 1, 2A), diagonal band of Broca and both medial and lateral divisions of the septum (Fig. 1) . Individual cells displaying relatively high GAT-1 mRNA signal were also detected throughout the cerebral cortex (Fig. 2) and caudate-putamen. Numerous cells expressing a relatively low GAT-1 mRNA signal were found in the preoptic area ( Fig. 2) and anterior hypothalamus.
Positively hybridized cells were detected in both the medial preoptic nucleus (MPN; Figs. 1, 2) and anteroventral periventricular nucleus (AVPv) of the preoptic area. A strong hybridization signal was noted in the suprachiasmatic nucleus and central division of the MPN (Fig.  1) . No signal was detected in sections hybridized in the presence of excess unlabelled GAT-1 probe; the mean number of silver grains detected over individual cells (n = 18-25) in excess control sections taken from the different GAT-1 mRNA hybridization experiments ranged from 3.6 to 4.8 silver grains/cell. The specificity of this oligonucleotide is demonstrated by (1) its detection of a single 4.5Kb band on Northern analysis (Augood et al., 1995) , (2) the ability to abolish GAT-1 mRNA signal in a competitive manner with a cold oligo, and (3) the observation that our distribution of GAT-1 mRNA is in good agreement with reports by others (mRNA: Rattray and Priestley, 1993; protein: Ikegaki et al., 1994) as well as our own previous work (Augood et al., 1995) .
Experiment I: efect of ovariectomy and estrogen-replacement on GAT-I mRNA expression In the first part of this experiment, GAT-1 mRNA expression in the AVPv, MPN, Mg-POA, caudate-putamen, and parietal cortex was examined in OVX and metestrous rats. A significant (p < 0.05) 25-30% decrease in GAT-1 mRNA signal was detected in the AVPv (30 2 4 silver grains/cell) and MPN (34 t 3) of ovariectomized rats compared with metestrous animals (AVPv, 43 ? 3; MPN, 45 t 2 silver grains/cell; Fig. 3 ). No differences were detected in the Mg-POA., caudate-putamen and parietal cortex (Fig. 3) In the second part of the experiment the effect of estrogen replacement on GAT-1 mRNA in the MPN and parietal cortex was evaluated in OVX, OVX-E24h and OVX-E7d rats. Within the MPN a significant 39% increase in GAT-1 mRNA signal was detected following 7 d, but not 24 hr, estrogen treatment (OVX, 56 ? 3 silver grains/cell; OVX-E24h, 69 2 4; OVXE7d, 78 t 8; ANOVA p < 0.05, post-hoc Dunn's test p < 0.05; Fig. 4 ). No significant difference was detected in GAT-1 mRNA signal within the parietal cortex of the three animal groups (OVX, 186 + 17 silver grains/cell; OVX-E24h, 214 + 18; OVX-E7d, 218 t 16; Fig. 4 ).
Experiment 2: effect of GVG treatment on GAT-I mRNA expression As the changes in GAT-1 mRNA content following 7 d of estrogen treatment may have resulted from direct actions of elevated GABA levels on GAT-1 mRNA content, an experiment was performed to assess the effect of increasing endogenous GABA levels for 7 d on GAT-1 mRNA expression. Ovariectomized rats receiving the GABA transaminase inhibitor GVG at a concentration of 150 mglkgld displayed no motor or arousal deficits. The tissue GABA content of preoptic area and parietal cortex punches from the left cerebral hemisphere of GVG-treated animals were two-to threefold greater (preoptic 130 + 9, cortex 80 2 7 nmol GABA/mg protein) than those of control animals (preoptic 68 ? 9, cortex 28 5 3 nmol GABA/mg protein; p < 0.01; Fig. 5 ). In situ hybridization experiments with the GAT-1 mRNA probe using the right hemisphere MPN and parietal cortex of these animals revealed no differences in GAT-1 mRNA expression between the GVG-and saline-treated rats in either brain region (Fig. 5 ).
Parietal Cortex
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Medial Preoptic Area
Saline GVG Saline GVG Saline GVG Figure 5 . Effect of y-vinyl GABA (GVG) treatment on tissue GABA (left) and cellular GAT-1 mRNA (n'ght) content in the parietal cortex and medial preoptic area. Note that GVG treatment increases tissue GABA content by approximately twofold (**, p < 0.01) compared with controls (saline) in both regions but has no effect on GAT-1 mRNA content. Pharmacological analyses in heterologous expression systems have shown that 10 PM nipecotic acid and 100 pM p-alanine are relatively specific inhibitors of GAT-I (50% inhibition but only 5-12% inhibition of GAT-2/3) and GAT-2/3 (70% inhibition but only 11% inhibition of GAT-1) transporters, respectively (Borden et al., 1992; Clark et al., 1992) . Addition of 10 pM nipecotic acid resulted in significant decreases in specific 'H-GABA uptake by all three brain regions (preoptic area, 47 + 9% decrease, p < 0.01; caudate-putamen, 37 ? 7% decrease, p < 0.05; parietal cortex, 21 -C 6% decrease, p < 0.05; n = 8-9). In contrast, 100 p,M p-alanine was found to have no significant effect on specific 3H GABA uptake in the parietal cortex or caudate-putamen (Fig. 6 ). In the preoptic area, p-alanine reduced 3H GABA uptake by 26 + 11% in OVX rats and by 32 + 9% in OVX+E7d rats, and when combined (n = 12), a significant 28 ? 4% reduction in 'H GABA uptake was observed (p = 0.05). Significant differences in total ?H-GABA uptake were observed between the three brain regions following either the 10 (ANOVA p < 0.01) or 20 (ANOVA p < 0.001) min incubation in ?H-GABA (Fig. 6) . In all cases, 'H-GABA uptake (dpm/pg protein) was significantly greater 0, < 0.05, Dunn's test) in the medial preoptic area compared with either the parietal cortex or caudate-putamen (Fig. 6) . Also, significantly more ?H-GABA was observed following the 20 min incubation compared with the 10 min exposure in all three brain regions (p < 0.05 preoptic area; p < 0.01 caudate-putamen and parietal cortex; Fig. 6 ). Estrogen treatment for 7 d had a significant @ < 0.05) effect in enhancing specific 'H-GABA uptake in pfeoptic punches following the 20 min incubation and 10 min incubation which included 100 PM @-alanine (Fig. 6) . A nonsignificant (p = 0.06) increase in uptake was observed in the normal 10 min incubation in the preoptic area. Estrogen treatment had no significant effect on specific 'H-GABA uptake in the parietal cortex or caudate-putamen (Fig. 6 ).
Discussion
These results provide evidence for a region-specific regulation of GABA transporter activity by estrogen in the female rat brain. Ovariectomy results in a significant decrease in cellular GAT-1 mRNA content in the medial preoptic area, but not cerebral cortex or caudate-putamen, and expression is returned to normal intact levels by 7 d estrogen treatment. Correspondingly, we show that 'H-GABA uptake in vitro is enhanced in the preoptic area but not the other brain regions by the same 7 d estrogen replacement paradigm. Pharmacological analysis suggests that tions, was only observed in the 10 min incubations in the presence of B-alanine when the majority of GAT-2 and GAT-3 transport is inhibited. Although the contribution of GAT-2 and/or GAT-3 to GABA uptake in the preoptic area may be relatively small, the use of B-alanine to reduce their influence on total GABA uptake enabled us to "unmask" the estrogen dependence of GAT-1 in 10 min incubations. The absence of any effect of estrogen on total 'H-GABA uptake in the caudate-putamen and pa&al cortex is in good agreement with our finding that GAT-1 mRNA is not influenced by ovarian steroid manipulations in these regions.
We hypothesized that changes in GABA transporter function within the medial preoptic area may underly differences in extracellular GABA concentrations observed in ovariectomized and estrogen-treated rats. Our observations are the opposite, however, of what we would have predicted as in vitro GABA transport and GAT-1 mRNA expression are increased, rather than decreased, at a time when GABA concentrations are relatively high in estrogen-treated rats. As such it was apparent that the increased GABA concentrations in the preoptic area may themselves regulate GAT-1 and that the changes in mRNA expression may be driven by alterations in endogenous GABA rather than estrogen. Accordingly, we carried out a further experiment to examine whether an increase in endogenous GABA levels achieved through inhibition of GABA transaminase, could influence GAT-1 mRNA expression. As an irreversible inhibitor of GABA-transaminase, GVG has been shown previously to increase GABA concentrations in a variety of brain regions following parenteral administration (Abdul-Ghani et al., 1980; Gale and Iadarola, 1980; Neal and Shah, 199Q; Rimvall et al., 1993; Jolkkonen et al., 1994) . Such increases in total GABA content are believed to represent elevations in neuronal and glial intracellular compartments as well as increases in extracellular GABA levels (Abdul-Ghani et -al., 1980; Gale and Iadarola, 1980; Neal and Shah, 1990) . In agreement with others we find that the 150 mg/kg/d dose of GVG does not alter behavior (Jolkkonen et al., 1994) and that 150-250 mg/kg/d results in a twoto threefold increase in total GABA content within the cerebral cortex as well as elsewhere in the brain (Neal and Shah, 1990; Rimvall et al., 1993; Jolkkonen et al., 1994) . This increase in GABA does not, however, influence GAT-1 mRNA expression in either the cerebral cortex or medial preoptic area and our results indicate that increases in intracellular and extracellular GABA levels do not influence GAT-I mRNA expression.
The mechanism by which estrogen increases basal GABA concentrations in the rat preoptic area remains unresolved. The changes in GABA transporter observed in this study are posi-tively correlated with endogenous GABA concentrations making it difficult to reconcile the increased basal GABA concentrations with elevated GABA transporter activity in this brain region. On the other hand, the estrogen-dependent increase in GABA transporter expression within the preoptic area may be responsible for the observed increases in potassium-stimulated GABA release (Herbison et al., 1989 through electrogenic reversal of the transporter (Fleischmann et al., 1992; Attwell et al., 1993) .
In terms of the basal GABA concentrations however, it is apparent that estrogen must increase GABA release rates in addition to increasing GABA transport to enable net increases in extracellular GABA concentrations to be detected. Our finding that estrogen also increases the expression of specific GABA, receptor subunit mRNAs in the preoptic area (Herbison and Fenelon, 1995) raises the likelihood that GABA, receptors may also be more abundant at the time we observe increased basal GABA concentrations. This multifaceted upregulation of the preoptic GABA network may be of physiological significance to a variety of behavioral and neuroendocrine mechanisms McCarthy et al., 1991) including the negative feedback actions of estrogen on the neural network controlling luteinizing hormone secretion . It remains to be established whether such changes are maintained into the afternoon of proestrus when positive feedback actions of estrogen are observed in concert with a disinhibition of the luteinizing hormone network by GABA (Jarry et al., 1988; . 
